Dermapharm Holding Dividend
Dividend criteriumcontroles 3/6
Dermapharm Holding is een dividendbetalend bedrijf met een huidig rendement van 2.83% dat ruimschoots wordt gedekt door de winst.
Belangrijke informatie
2.8%
Dividendrendement
n/a
Terugkoop Rendement
Totaal aandeelhoudersrendement | n/a |
Toekomstig dividendrendement | 4.1% |
Dividendgroei | 7.8% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | €0.880 |
Uitbetalingsratio | 57% |
Recente dividendupdates
Recent updates
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: DMP betaalt al minder dan 10 jaar dividend en gedurende deze periode zijn de betalingen volatiel geweest.
Groeiend dividend: De dividendbetalingen van DMP zijn gestegen, maar het bedrijf heeft pas 6 jaar dividend uitgekeerd.
Dividendrendement versus markt
Dermapharm Holding Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (DMP) | 2.8% |
Markt onderkant 25% (DE) | 1.6% |
Markt Top 25% (DE) | 4.8% |
Gemiddelde industrie (Pharmaceuticals) | 1.2% |
Analist prognose (DMP) (tot 3 jaar) | 4.1% |
Opmerkelijk dividend: Het dividend van DMP ( 2.83% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de German markt ( 1.64% ).
Hoog dividend: Het dividend DMP ( 2.83% ) is laag vergeleken met de top 25% van dividendbetalers in de German markt ( 4.77% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn redelijke payout ratio ( 57.2% ) worden de dividendbetalingen van DMP gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 32.5% ) worden de dividendbetalingen van DMP goed gedekt door de kasstromen.